skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

15370

Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers



Original Research

(5223) Total Article Views


Authors: Carole Decker, Linda Garavalia, Brian Garavalia, John A Spertus

Published Date June 2008 Volume 2008:2 Pages 167 - 175
DOI: http://dx.doi.org/10.2147/PPA.S3443

Carole Decker1, Linda Garavalia2, Brian Garavalia1, John A Spertus1

1Mid America Heart Institute, Saint Luke’s Hospital, Kansas City, MO, USA; 2Department of Psychology, University of Missouri, Kansas City, MO, USA

Background: Each day, patients make choices whether or not to take their prescribed medications. Previous research has shown that 1 in 7 myocardial infarction (MI) patients discontinued thienopyridines within 1 month of receiving a drug-eluting stent (DES) with serious consequences. This qualitative research study explored in depth the clopidogrel-taking behavior among DES-treated patients who quit taking clopidogrel 1 month after treatment and those who continued therapy.

Methods: Sequential patients from a prospective MI registry who reported discontinuing clopidogrel within 30 days of DES treatment (N = 11) were matched with continuers (N = 11). Both groups underwent detailed qualitative phone interviews. Coding and thematic representation using directed qualitative content analysis by 3 PhD researchers was done.

Results: Patients were 41–77 years old and the majority was Caucasian and male. Multiple barriers were described by discontinuers that were not reported by continuers. The most frequently cited barrier was misunderstanding the intended duration of treatment. Discontinuers also described system weaknesses that contributed to early discontinuance such as gaps in the transition to primary care.

Conclusions: While premature discontinuation of a prescribed therapy is viewed by clinicians as a willful disregard for medical advice, early stopping of clopidogrel is influenced greatly by processes of care and system issues.

Keywords: medication discontinuance, drug-eluting stent post-care, myocardial infarction




Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter

 

Other articles by Dr Carole Decker


Readers of this article also read: